IL2 and colitis: In the DSS-induced colitis group, there were substantial reductions in zonula occludens-1 (ZO-1) and occludin mRNA levels; however, these recovered to the control levels in the low-dose IL-2 groups (16K IU/day and 32K IU/day) (Figure 4D).